X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FNCH

Closed

Finch Therapeutics Group Inc

12.5
-0.7 (-5.30%)
Last Update: 30 Jun 2025 18:19:00
Yesterday: 13.2
Day's Range: 12.5 - 12.5
Send
When Written:
 
0.393
Finch Therapeutics Group Inc is a biotechnology company that specializes in developing microbiome-based therapies. The company was founded in 2016 and is headquartered in Somerville, Massachusetts. Finch Therapeutics uses a proprietary platform to identify and isolate specific strains of bacteria from the human gut microbiome, which can be used to treat a variety of diseases and conditions. The company's lead product candidate, CP101, is a microbiome-based therapy for the treatment of recurrent Clostridioides difficile infection (rCDI). Finch Therapeutics has also partnered with Takeda Pharmaceutical Company to develop microbiome-based therapies for inflammatory bowel disease (IBD).

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X